Implementation of medical devices future regime
A roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices and an intended policy on international recognition.
- From:
- Medicines and Healthcare products Regulatory Agency
- Published
- 25 October 2022
- Last updated
-
322JulyOctober 2024 — See all updates
Documents
Roadmap towards the future regulatory framework for medical devices
PDF, 363 KB, 3 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
AnnexANNEX A:A- Detailed response to WTO comments for The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Draft Regulations 2023
PDF, 166 KB, 8 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
Overview
On 26 June 2022, MHRA published the government response to the public consultation on the future regulation of medical devices in the United Kingdom. The response outlined the intended regulatory reform including the transitional arrangements for CE marked devices placed on the Great Britain market which were put in place in 2023.
On 9 January 2024, the MHRA released a Roadmap towards the future regulatory framework for medical devices. This provides an update on the intended timelines to implement the future core regulations.
On 21 May 2024, following on from stakeholder discussions throughout the first quarter of 2024, MHRA released a statement of policy intent for recognition by the UK of approvals of medical devices from international regulators. This statement sets out MHRA’s proposed policy approach. The final legal text would come into force at the same time as the future core regulations.
Contact
For further information, please email our Customer Services Centre at info@mhra.gov.uk or call 020 3080 6000. Alternatively, contact your Trade Association by emailing:
- Association of the British HealthTech Industries (ABHI): enquiries@abhi.org.uk
- British In Vitro Diagnostics Association (BIVDA): enquiries@bivda.org.uk
- Proprietary Association of Great Britain (PAGB): regulatory@pagb.co.uk
- The British Healthcare Trades Association (BHTA): info@bhta.com
- UK Responsible Persons Association (UKRPA): enquiries@ukrp-association.org
Updates to this page
Last updated
-
On 21 October 2024, the draft Post-Market Surveillance statutory instrument was laid in Parliament. The new regulations will introduce clearer and more robust requirements for PMS that improve patient safety.
-
Updated to include intended policy on international recognition and consultation on common specifications for in vitro diagnostic medical devices (IVDs).
-
Link to webinar 'MHRA MedTech Regulatory Reform' added to section 4.
-
Added 'Roadmap for the Implementation of the Future Regulatory Framework for Medical Devices' and information about 'future core regulations'.
-
Updated guidance to reflect that the the World Trade Organisation (WTO) has published the draft Post Market Surveillance Requirements Statutory Instrument.
-
Implementation of the Future Regulations updated to include note on the reviewing of our position on the acceptance of EU MDR and EU IVDR CE certificates.
-
This guidance has been updated now that the Government has made regulations that enable CE marked medical devices to continue to be accepted in Great Britain for defined periods beyond 30 June 2023
-
Published overview of timelines for placing CE marked IVDs on the Great Britain market
-
This guidance was updated to reflect an intended extension to acceptance of CE marked medical devices on the Great Britain market beyond 30 June 2023
-
First published.
Sign up for emails or print this page
Update history
2026-02-16 10:00
Updated with information about the consultation on indefinite recognition of CE marking and updates about the Pre-market SI following the publication of consultation responses in July 2025.
2025-12-15 16:00
Added link to ‘In Vitro Diagnostic (IVD) Medical Device roadmap’, which was published 15 December 2025.
2025-02-26 07:00
Section 4 updated to include information about consultation response.
2025-01-15 10:00
Updated to reflect the laying of The Medical Devices (Post-market Surveillance requirements) (Amendment) Regulations 2024.
2024-12-11 16:00
Published a revised ‘Roadmap towards the future regulatory framework for medical devices’.
2024-11-14 00:01
Updated to include a link to the MHRA’s Consultation on Medical Devices Regulations: Routes to market and in vitro diagnostic devices, and to update the list of topics to be included in the ‘pre-market’ regulations.
2024-10-22 10:00
On 21 October 2024, the draft Post-Market Surveillance statutory instrument was laid in Parliament. The new regulations will introduce clearer and more robust requirements for PMS that improve patient safety.
2024-07-03 11:14
Guidance updated following laying of a statutory instrument in parliament setting out new legislation on post-market surveillance.
2024-05-21 09:00
Updated to include intended policy on international recognition and consultation on common specifications for in vitro diagnostic medical devices (IVDs).
2024-03-28 09:11
Link to webinar ‘MHRA MedTech Regulatory Reform’ added to section 4.